drugset / Trial / NCT00002181

Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS

NCT00002181 ↗

Completed Gilead Sciences
Open-labelTreatment

Summary

The purpose of this study is to see if cidofovir gel (Forvade) is safe and effective in treating herpes simplex in patients with AIDS who do not respond to acyclovir.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject CIDOFOVIR ANHYDROUS Small molecule — —